Ganno Hideaki, Kawaguchi Machiko, Umebayashi Yuya, Aoyama Syouta, Sugita Hirofumi, Noguchi Takeharu, Amagasa Hidetoshi, Imai Kenichiro, Ami Katsunori, Fukuda Akira, Aoki Nobuhiko, Ando Masayuki, Tei Shikofumi
Dept. of Surgery, Tokyo Metropolitan Health and Medical Treatment Corporation, Toshima Hospital.
Gan To Kagaku Ryoho. 2016 Nov;43(12):1730-1732.
We report a case of resection of a paraaortic lymph node recurrence, wherein complete response to bevacizumab was observed. Our patient was a 50-year-old woman who had a paraaortic lymph node recurrence during adjuvant chemotherapy with FOLFOX 6 months after surgery for sigmoid colon cancer. She was treated with chemotherapy consisting of FOLFOX plus bevacizumab/FOLFIRI plus bevacizumab, which suppressed progression of the periaortic lymph node recurrence. She underwent surgery for the paraaortic lymph node recurrence, and the pathologic result was complete response. We report that bevacizumab was effective for her paraaortic lymph node recurrence.
我们报告了一例主动脉旁淋巴结复发切除术的病例,其中观察到对贝伐单抗有完全反应。我们的患者是一名50岁女性,在乙状结肠癌手术后6个月接受FOLFOX辅助化疗期间出现主动脉旁淋巴结复发。她接受了由FOLFOX加贝伐单抗/FOLFIRI加贝伐单抗组成的化疗,这抑制了主动脉旁淋巴结复发的进展。她接受了主动脉旁淋巴结复发的手术,病理结果为完全反应。我们报告贝伐单抗对她的主动脉旁淋巴结复发有效。